SymBiosis Capital Partners »

Surrozen shares owned by SymBiosis Capital Partners

Quarter-by-quarter ownership of Surrozen (SRZNW) shares owned by SymBiosis Capital Partners from 13F filings

Historical chart of SymBiosis Capital Partners investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by SymBiosis Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by SymBiosis Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4k 150k 0.02

More positions owned by SymBiosis Capital Partners

Evommune Com Shs (EVMN)
Inventiva Ads (IVA)
Wave Life Sciences SHS (WVE)
Rani Therapeutics Holdings Com Cl A (RANI)
Clene Nanomedicine Com New (CLNN)
Surrozen *w Exp 08/01/203 (SRZNW)

View all positions for SymBiosis Capital Partners

Top funds holding Surrozen

Baker Bros. Advisors
LMR Partners
Bridger Management
Euclidean Capital
Perceptive Advisors
Deerfield Management Company
SymBiosis Capital Partners
Arrowpoint Asset Management
Citigroup
Regents of the University of California
Millennium Management
Boxer Capital Management
Trustees of Columbia University in the City of New York
Virtu Financial
EcoR1 Capital

View all funds holding Surrozen